加科思药业集团有限公司（股票代码：01167）于2026年3月18日发布翌日披露报表，公告显示公司当日通过香港联交所场内回购144,000股股份，占回购前已发行股份总数约0.0183%。回购价介乎每股港币6.89元至7.01元，合计支付总额约港币998,043元。
本次回购后，公司已发行股份（不包括库藏股）总数为786,345,780股，库藏股数为5,409,300股。根据公告，公司于2025年6月10日通过了股份回购授权，可回购股份总数为78,873,528股，而截至目前已在交易所累计回购2,389,500股。公司确认已遵守香港联交所相关上市规则及法例。本次公告由公司董事王晓洁签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.